Cargando…
Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study
BACKGROUND: Major bleedings other than gastrointestinal (GI) and intracranial (ICH) and mortality rates associated with antiplatelet drugs in real-world clinical practice are unknown. The objective was to estimate major bleeding risk and mortality among new users of antiplatelet drugs in real-world...
Autores principales: | Bouget, Jacques, Balusson, Frédéric, Viglino, Damien, Roy, Pierre-Marie, Lacut, Karine, Pavageau, Laure, Oger, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413418/ https://www.ncbi.nlm.nih.gov/pubmed/32764775 http://dx.doi.org/10.1371/journal.pone.0237022 |
Ejemplares similares
-
Major gastrointestinal bleeding and antithrombotics: Characteristics and management
por: Bouget, Jacques, et al.
Publicado: (2020) -
Sensitivity and specificity of an algorithm based on medico-administrative data to identify hospitalized patients with major bleeding presenting to an emergency department
por: Oger, Emmanuel, et al.
Publicado: (2019) -
Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases
por: George, Gincy, et al.
Publicado: (2020) -
Antiplatelets/enoxaparin-sodium: Major bleeding: case report
Publicado: (2020) -
Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)